The RAPS website will be under maintenance starting at 5 pm Eastern on Friday, October 1, 2021 until 8 am on Monday, October 4, 2021.
Portions of the website may be inaccessible during this time. We apologize for any inconvenience.

  • Regulatory NewsRegulatory News

    Canada Reimbursement Profile

    This profile summarizes reimbursement processes in Canada, presents information for key stakeholders and highlights what should be considered early in the development process. Obtaining regulatory approval for medicines is the first major hurdle of most pharmaceutical and biotechnology companies looking to launch their products worldwide. However, obtaining market access once products are approved by regulatory agencies (e.g., Health Canada) is a separate and crucial p...
  • Canada: CADTH Finds Urine Test as Good as Blood for Type II Diabetes Monitoring

    The Canadian Agency for Drugs and Technologies in Health (CADTH) Rapid Response Report found in patients with type II diabetes no statistically significant difference between two self-monitoring strategies, urine and blood testing, in glycemic control, measured by HbA1c levels, or in the proportion of patients reaching target HbA1c.  It concluded that findings from large randomized controlled trials comparing benefits of the two monitoring strategies and economic ...